Spring 2024 funding cycle: Applications closed, funding results available before end of May 2024
Fall 2024 funding cycle:
- Call opens: Thursday, August 29, 2024
- Deadline: Monday September 30, 2024 (2:00 pm PST)
- Funding results: available before end of December, 2024
Amount available: $50,000 in direct costs for 1 year
Apply through the UCSF Resource Allocation Program (RAP) portal
The CFAR Mentored Scientist Award (our primary award program) is a mentoring and training grant targeted toward early stage (either at a senior stage of clinical or postdoctoral training or junior faculty) investigators at UCSF or affiliated partner institutes in the conduct of an HIV research project. These awards are designed to acquire preliminary data and research skills to prepare investigators for a future grant effort. Applicants for this award must indicate a faculty research mentor(s) who will commit to guiding the applicant throughout the duration of the proposed project.
Designation of Mentor
All Mentored award applications from individuals at the Assistant Professor level or below require an HIV research mentor. Mentors can, but are not required to, have supervisory authority over the applicant. CFAR requires your research mentor’s support to advise and guide the research portion of your application before submitting it to RAP.
Of high interest to CFAR are investigations ranging from basic pathogenesis to clinical outcomes in the research areas of HIV/aging and inflammation, latency, cure, vaccines, co-infections, HIV in women, implementation science, and research related to health disparities in HIV-infected and HIV-impacted Bay Area populations. Projects must be within NIH’s HIV/AIDS research high or medium priority areas. Projects in closely related areas (e.g. TB, HCV, drug use, etc.) must be clearly linked to HIV in order to be eligible for CFAR funding.
The award amount is $50,000 in direct costs for one year.
For more detailed information about this RFA, please see the RAP Portal.
To see examples of previously funded projects, see the list below.
Mentored Science Awardees
123 Awards
-
Locating perceptions of HIV acquisition and transmission risks among people who inject drugs in West Virginia
Locating perceptions of HIV acquisition and transmission risks among people who inject drugs in West Virginia
Abstract
West Virginia has some of the highest risk areas in the country for HIV transmission. Opioid use, particularly through injection, has risen dramatically in the state which also has the nation’s highest drug overdose death rate.
-
Exploring the intersection of food insecurity and violence among women in the Women’s Interagency HIV Study (WIHS)
Exploring the intersection of food insecurity and violence among women in the Women’s Interagency HIV Study (WIHS)
Abstract
Food insecurity, which refers to having limited or uncertain availability of nutritionally adequate and safe food, and violence are prevalent among women in the United States, and disproportionately affect HIV-positive women. Both food insecurity and violence are associated with negative health behaviors and outcomes including HIV risk behaviors, chronic diseases, poor mental health, and reduced engagement in HIV care and treatment. Evidence suggests that food insecurity is associated with increased risk for intimate partner violence (IPV).
-
Are extracellular vesicles involved in the pathogenesis of HIV-associated cardiovascular disease?
Are extracellular vesicles involved in the pathogenesis of HIV-associated cardiovascular disease?
Abstract
HIV-infected individuals on antiretroviral therapy have higher than expected rates of cardiovascular disease (CVD) than uninfected individuals, and HIV-induced chronic inflammation is believed to be directly and causally associated with the accelerated atherosclerosis development. Prior studies have revealed that chronic inflammatory states, such as atherosclerosis, show significantly increased levels of circulating endothelium-derived extracellular vesicles (EVs), which are preferentially taken up by monocytes and lead to monocyte activation.
-
The role of pulmonary myeloid cells in HIV-related COPD in individuals on anti-retroviral therapy
The role of pulmonary myeloid cells in HIV-related COPD in individuals on anti-retroviral therapy
Abstract
Dr. Joshua Vásquez, MD, Assistant Professor in the Division of Experimental Medicine and the Division of Pulmonary and Critical Care Medicine at UCSF who is establishing himself as a clinician-scientist in HIV immunology. This award will provide him with preliminary data and support to apply for future funding for projects aimed at: (1) characterizing the pulmonary reservoir of HIV and (2) to determining whether defects in alveolar macrophages are associated with HIV-related chronic obstructive pulmonary disease and persist, despite antiretroviral therapy.
-
Objective medication adherence monitoring for geographically mobile persons living with HIV
Objective medication adherence monitoring for geographically mobile persons living with HIV
Abstract
Populations in sub-Saharan Africa are the most mobile in the world: up to 80% of households have at least one migrant member. Mobility is a risk factor for HIV transmission, but its impact on medication adherence for persons living with HIV (PLHIV) remains poorly understood. We will leverage the ongoing study Understanding Mobility and Risk in SEARCH Communities (RO1MH104132), which has followed over 1100 PLHIV from 12 East African communities since 2016, to study this association.
-
Sprouty 1 and 2 Regulation of Cytotoxicity in HIV-specific CD8+ T Cells
Sprouty 1 and 2 Regulation of Cytotoxicity in HIV-specific CD8+ T Cells
Abstract
The poor cytotoxicity of CD8+ T cells against cells harboring reactivated HIV which have a low expression of viral antigens presents a profound barrier to the success of HIV cure strategies. Discovering new pathways that safely enhance the function of cytotoxic T-lymphocytes (CTLs) has immense potential for harnessing CTLs for the ‘shock and kill’ approach. While in a quiescent state, HIV-infected resting CD4+ T cells do not express sufficient HIV antigens and, thus, are not targeted by CTLs.
-
Gut metabolites and their role in diastolic dysfunction in HIV+ individuals
Gut metabolites and their role in diastolic dysfunction in HIV+ individuals
Abstract
Considerable progress in the recognition, diagnosis, and treatment of HIV has led to a significant increase in the life expectancy of this population. With this change, however, HIV+ individuals are at higher risk of developing certain co-morbidities including cardiovascular disease (CVD). HIV infection has emerged as an independent risk factor for left ventricular diastolic dysfunction (DD), predisposing these individuals to chronic illnesses including atrial fibrillation, pulmonary hypertension, and heart failure with preserved ejection fraction (HFpEF).
-
Modeling the impacts of HIV self-testing among men who have sex with men in South Africa
Modeling the impacts of HIV self-testing among men who have sex with men in South Africa
Abstract
In many countries with high HIV prevalence, there exists extensive stigma and discrimination against sexual minorities. In South Africa, national HIV prevention programs have largely failed to tailor HIV testing services to these marginalized, key populations, including Men who have Sex with Men (MSM). As a result, MSM have some of the highest HIV prevalence estimates in the country (33.9%) and are not testing at rates commensurate with their risk.
-
Epigenetic architecture of stress among sexual minority men living with HIV
Epigenetic architecture of stress among sexual minority men living with HIV
Abstract
Sexual minority (i.e., non-heterosexual) populations experience higher rates of mental health disorders and health related problems. Unique stressors such as discriminatory experiences, expectations of discrimination, internalization of social stigma, and concealment of sexual orientation, collectively termed “sexual minority stress”, are the primary explanatory model for these health disparities.
-
Pneumo-seq pathogen and antimicrobial resistance surveillance in Ugandan HIV positive adults with pneumonia
Pneumo-seq pathogen and antimicrobial resistance surveillance in Ugandan HIV positive adults with pneumonia
Abstract
Pneumonia is the leading cause of death amongst HIV positive persons in Uganda and other resource limited countries. Antimicrobial resistance is rising at an alarming rate throughout the world and complicating the treatment of both pneumonia and tuberculosis. Understanding region-specific microbial causes of pneumonia and their drug resistance attributes is critical for developing successful empiric therapeutic algorithms.